520 results on '"Ingelmo M"'
Search Results
2. Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma
3. Anti-Granulocyte Perinuclear Antibodies but Not Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Rheumatoid Arthritis
4. Anti-Neutrophil Cytoplasmic Autoantibodies (ANCA): Antigenic Specificities and Clinical Associations
5. A0706 - Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma
6. Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship?
7. Deformaciones de términos griegos
8. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients
9. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome
10. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients
11. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients
12. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients
13. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
14. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy
15. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögrenʼs syndrome
16. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögrenʼs syndrome. Correlation with clinical, immunological and histological features
17. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level
18. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögrenʼs syndrome
19. ANTIPHOSPHOLIPID SYNDROME (APS): PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS.
20. Cardiac toxicity secondary to long term treatment with chloroquine
21. Cardiovascular risk factors and the long-term outcome of lupus nephritis
22. Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)
23. Optic neuropathy in the “primary” antiphospholipid syndrome: Report of a case and review of the literature
24. Identification of a natural soluble form of human CD5
25. Prosthetic valve endocarditis caused by corynebacterium pilosum
26. Q Fever and Hemolytic Anemia
27. Skin Necrosis After Heparin Injection
28. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the 'Euro-Lupus Project'
29. Anticardiolipin antibodies in patients with autoimmune diseases: Isotype distribution and clinical associations
30. Lessons from the 'Euro-Lupus Cohort'
31. European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the 'Euro-Lupus Project'
32. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
33. European Working Party on Systemic Lupus Erythematosus. Lessons from the 'Euro-Lupus Cohort'
34. Morbidity and mortality insystemic lupus erythematosus during a 5-year period. A multicenter prospectivestudy of 1,000 patients. European Working Party on Systemic Lupus Erythematosus
35. 237 MicroRNA signature associated with poor outcome in upper urinary tract tumours
36. Amegakaryocytic Thrombocytopenia and an Analgesic
37. [Primary antiphospholipid syndrome: clinical and biological study of 36 cases]
38. Lessons from the 'Euro-Lupus Cohort'
39. Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients
40. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients
41. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients
42. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus
43. OP0043 A study of overlaping infectious, autoimmune and haematological etiologies in cryoglobulinemia in a tertiary universitary hospital
44. FRI0213 Raynaud’s phenomenon in primary sjÖgren’s syndrome. prevalence and clinical characteristics in a series of 320 patients
45. OP0067 Usefulness of the basal and pilocarpine-stimulated salivary flows in primary sjÖgren’s syndrome
46. Syndrome des anticorps antiphospholipides : caractéristiques cliniques et biologiques de 1 000 patients (euro-phospholipid project)
47. Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease
48. Increased serum levels of solublel-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)
49. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature
50. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.